Compound brain protein hydrolysate tablets
Function and Efficacy
1. Pharmacology: This product can increase the content of neurotransmitters Ach, NA, DA and 5-HT in the brain; increase the density of the capillary network in the brain of young animals and promote the differentiation of animal brain nerve cells; stimulate the diencephalon-pituitary system to release growth hormone and thyroxine to promote the growth and development of animals; improve the amino acid metabolism of brain cells and promote protein synthesis; promote the normalization of glucose transport; improve the brain's ability to resist ischemia and hypoxia; provide precursors of neurotransmitters, peptide hormones and coenzymes; activate adenylate cyclase and catalyze other hormone systems; improve memory, dilate cerebral blood vessels, and improve brain blood circulation. 2. Toxicology: In the acute toxicity test of mice, no toxicity of this drug was observed, and its maximum tolerance was at least 156 times the conventional dose. The results of long-term toxicity tests on rats showed that the conventional dose had no obvious toxic and side effects on the brain, heart, lungs, spleen, kidneys, testicles, ovaries and other organs of rats, and had no effect on blood counts, liver and kidney functions.
Ingredients
Brain protein hydrolysate, glutamic acid, chondroitin sulfate, vitamin B1, vitamin B6.
| Name | Description | Content | CAS NO. | Manufacturer |
|---|---|---|---|---|
| L-Glutamic acidIngredients |
Promote neurotransmitter synthesis and improve brain function More |
56-86-0 | 18 | |
| Chondroitin 4-sulfateIngredients |
Improve brain cell metabolism, promote normalization of glucose transport, and enhance resistance to ischemia and hypoxia More |
9007-28-7 | 2 | |
| Thiamine chlorideIngredients |
Participate in energy metabolism and improve nervous system function More |
59-43-8 | 9 | |
| Vitamin B6Ingredients |
Participate in amino acid metabolism and promote neurotransmitter synthesis More |
8059-24-3 | 13 |
Appearance
This product is a film-coated tablet. After removing the coating, it appears light yellow or brownish yellow.
Indication
It is used to improve the symptoms of craniocerebral trauma, cerebrovascular disease sequelae accompanied by memory loss and attention disorder. It has an auxiliary improvement effect on brain dysfunction, and is also used for patients with protein deficiency, neurasthenia and general protein digestion and absorption disorders.
Usage and Dosage
Oral administration. 3 times a day, 4 tablets each time for adults, and less for children or as directed by a doctor.
Adverse Reactions
No adverse reactions have been reported.
Precautions
1. It is contraindicated for patients with epilepsy. 2. It is contraindicated for patients with severe renal dysfunction. 3. It is contraindicated for patients who are allergic to this product. 4. It is contraindicated for pregnant and lactating women.
Special Population Medication
Precautions for children: Reduce dosage for children or follow doctor's advice. Precautions for pregnancy and lactation: Pregnant and lactating women are prohibited. Precautions for the elderly: Follow doctor's advice.
Drug Interactions
1. When taking it with antidepressants, it is recommended to reduce the latter's dosage. 2. When taking monoamine oxidase inhibitors at the same time, the drug effects will be additive.
Storage
Sealed, store in a cool, dry place.
Packaging Specification
Compound
Validity Period
24 months.
Manufacturer
Jiangsu Hengxin Pharmaceutical Co., Ltd.
-
Founded in:
2002-08-02 -
Address:
No. 296, Chuqiao Road, Dingmao, Zhenjiang New District -
Tax NO.:
913211917413307793 -
Registered Funds:
12.7 million yuan -
Website:
-
Email: